News|Articles|October 2, 2025

11 Dermatology Headlines You Missed in September 2025

Author(s)Tim Smith
Fact checked by: Abigail Brooks, MA

This review of the month of September highlights some of the most significant dermatology headlines.

In September 2025, a wide range of developments have transpired in the field of dermatology, including new research into dermatologic disease states and approvals of medications such as remibrutinib and guselkumab by the US Food and Drug Administration (FDA).